WNK2 and breast cancer: Controversially, Wang et al. showed in vitro and in vivo that BCG can increase the PD-L1 expression of BC cells via the mitogen-activated protein kinase (MAPK) pathway, which may lead to a reduced effect of cytotoxic T-lymphocytes [82,83].